Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Leroy

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2019
Natural History of Recurrent Alcohol-Related Cirrhosis After Liver Transplantation: Fast and FuriousDomitille Erard-Poinsot, Sébastien Dharancy, Marie-Noëlle Hilleret, et al.
Transplantation|July 26, 2016
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter StudyFaouzi Saliba, Lionel Rostaing, Jean Gugenheim, et al.
Journal of Hepatology|May 11, 2010
Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesisNathalie Sturm, Marie-Ange Thélu, Xavier Camous, et al.
Clinical Transplantation|October 24, 2009
Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcomeAndrea De Gottardi, Marie-Noelle Hilleret, Pascale Gelez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2019
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 YearsFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Open Forum Infectious Diseases|January 16, 2026
Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)Patrick Ingiliz, Erwan Vo Quang, Gibril Ndow, et al.
Clinics and Research in Hepatology and Gastroenterology|September 19, 2022
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantationAudrey Coilly, Mylène Sebagh, Claire Fougerou-Leurent, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2023
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxisFrançois Villeret, Fanny Lebossé, Sylvie Radenne, et al.
Journal of Clinical Microbiology|November 21, 2014
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patientsSylvie Larrat, Om Kulkarni, Jean-Baptiste Claude, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2019
Natural History of Recurrent Alcohol-Related Cirrhosis After Liver Transplantation: Fast and FuriousDomitille Erard-Poinsot, Sébastien Dharancy, Marie-Noëlle Hilleret, et al.
Transplantation|July 26, 2016
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter StudyFaouzi Saliba, Lionel Rostaing, Jean Gugenheim, et al.
Journal of Hepatology|May 11, 2010
Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesisNathalie Sturm, Marie-Ange Thélu, Xavier Camous, et al.
Clinical Transplantation|October 24, 2009
Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcomeAndrea De Gottardi, Marie-Noelle Hilleret, Pascale Gelez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2019
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 YearsFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
The New England Journal of Medicine|October 12, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal ImpairmentEdward Gane, Eric Lawitz, David Pugatch, et al.
Open Forum Infectious Diseases|January 16, 2026
Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)Patrick Ingiliz, Erwan Vo Quang, Gibril Ndow, et al.
Clinics and Research in Hepatology and Gastroenterology|September 19, 2022
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantationAudrey Coilly, Mylène Sebagh, Claire Fougerou-Leurent, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2023
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxisFrançois Villeret, Fanny Lebossé, Sylvie Radenne, et al.
Journal of Clinical Microbiology|November 21, 2014
Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patientsSylvie Larrat, Om Kulkarni, Jean-Baptiste Claude, et al.
Pageof 18